Morning melatonin has limited benefit as a soporific for daytime sleep after night work.
Exogenous melatonin administration in humans is known to exert both chronobiotic (phase shifting) and soporific effects. In a previous study in our lab, young, healthy, subjects worked five consecutive simulated night shifts (23:00 to 07:00 h) and slept during the day (08:30 to 15:30 h). Large phase delays of various magnitudes were produced by the study interventions, which included bright light exposure during the night shifts, as assessed by the dim light melatonin onset (DLMO) before (baseline) and after (final) the five night shifts. Subjects also ingested either 1.8 mg sustained-release melatonin or placebo before daytime sleep. Although melatonin at this time should delay the circadian clock, this previous study found that it did not increase the magnitude of phase delays. To determine whether melatonin had a soporific effect, we controlled the various magnitudes of phase delay produced by the other study interventions. Melatonin (n=18) and placebo (n=18) groups were formed by matching a melatonin participant with a placebo participant that had a similar baseline and final DLMO (+/-1 h). Sleep log measurements of total sleep time (TST) and actigraphic measurements of sleep latency, TST, and three movement indices for the two groups were examined. Although melatonin was associated with small improvements in sleep quality and quantity, the differences were not statistically significant by analysis of variance. However, binomial analysis indicated that melatonin participants were more likely to sleep better than their placebo counterparts on some days with some measures. It was concluded that, the soporific effect of melatonin is small when administered prior to 7 h daytime sleep periods following night shift work.
Smith
Mark R
MR
Biological Rhythms Research Laboratory, Rush University Medical Center, Chicago, IL 60612, USA.
Lee
Clara
C
Crowley
Stephanie J
SJ
Fogg
Louis F
LF
Eastman
Charmane I
CI
D000328:Adult; D002940:Circadian Rhythm / Q000187:drug effects* / Q000502:physiology; D003624:Darkness; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008027:Light; D008297:Male; D008550:Melatonin / Q000008:administration & dosage* / Q000378:metabolism / Q000494:pharmacology*; D017440:Photoperiod; D010919:Placebos; D012463:Saliva / Q000378:metabolism; D012890:Sleep / Q000187:drug effects* / Q000502:physiology; D020178:Sleep Disorders, Circadian Rhythm / Q000188:drug therapy; D013997:Time Factors; D014937:Work
D003692:Delayed-Action Preparations; D010919:Placebos; D008550:Melatonin